A Closer Look at Regeneron Pharmaceuticals's Options Market Dynamics
Portfolio Pulse from Benzinga Insights
The options market for Regeneron Pharmaceuticals (NASDAQ:REGN) shows a bearish sentiment, with 58% of trades being bearish. The stock is currently trading at $1034.78, down by 1.07%. Analysts have mixed ratings, with price targets ranging from $1015 to $1300.
September 25, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is experiencing bearish sentiment in the options market, with 58% of trades being bearish. The stock is currently down 1.07% at $1034.78. Analysts have mixed ratings, with price targets ranging from $1015 to $1300.
The options market shows a significant bearish sentiment with 58% of trades being bearish, which could indicate a short-term downward pressure on the stock price. The stock is already down by 1.07%, and mixed analyst ratings with some downgrades suggest uncertainty about the stock's near-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100